Computational modeling as a tool to investigate PPI: from drug design to tissue engineering
Practical considerations for the treatment of elderly patients with migraine
What This Isn't 5-Amino-1MQ is not: A replacement for GLP-1 therapy A stimulant A well-studied human compound (animal data only for the fat loss mechanism) Something to stack recklessly at high doses without bloodwork The mechanism is legitimate and the animal data is compelling
Appendices Appendix 1: Modified NHS bath flowchart (Knechtli and Crowe 2010) Appendix 2: Jan 2019 audit data collection form Appendix 3: Jul 2019 re-audit data collection form Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
Biohacker Protocol (experimental) Dose: 0.25 mg (variant 5 mg pen = 10 clicks / variant 10 mg pen = 5 clicks) Duration: Continuous Frequency: Daily Cycle Interval: Daily Goal / Description: Microdose for systemic recovery studies
